Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 20/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21400055 | 1.00 | AGTR2 (0.67) | AGTR2 | |
| SCHEMBL23032436 | 0.86 | AGTR2 (0.61) | AGTR2 | |
| SCHEMBL21400064 | 0.86 | AGTR2 (0.61) | AGTR2 | |
| SCHEMBL23032445 | 0.85 | AGTR2 (0.50) | AGTR2 | |
| SCHEMBL21400117 | 0.81 | AGTR2 (0.78) | AGTR2 | |
| SCHEMBL21400059 | 0.80 | AGTR2 (1.00) | AGTR2 | |
| SCHEMBL23032082 | 0.79 | ALDH1A1 (0.44) | AGTR2 | |
| SCHEMBL22917382 | 0.78 | AGTR2 (0.73) | AGTR2 | |
| SCHEMBL23032405 | 0.76 | AGTR2 (0.91) | AGTR2 | |
| SCHEMBL23032473 | 0.73 | AGTR2 (1.00) | AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066398-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2025-02-27 | — | — | US | disclosed |
| US-12180243-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2024-12-31 | — | — | US | disclosed |
| EP-3770148-B1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2024-10-02 | — | — | EP | disclosed |
| US-20230106958-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2023-04-06 | — | — | US | disclosed |
| US-11453690-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2022-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230106958-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | AGTR2 14/4885 |
| US-11453690-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | TACR1, TACR2, GPBAR1 | AGTR2 14/4885 |
| US-20250066398-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | AGTR2 14/4885 |
| US-12180243-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | TACR1, TACR2, GPBAR1 | AGTR2 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.